P eriodontitis is a chronic bacterial infection of tooth-supporting structures. It causes destruction of periodontal connective tissue and bone and, in severe cases, tooth loss. Key oral plaque bacteria including Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans, and Tanerella forsythia are recognized as etiologic agents in periodontitis. The disease initiation and progression results from the host response to plaque bacteria. Immunohistochemistry studies reveal dense cellular infiltration, including numerous T and B cells in periodontitis lesions. In addition, high levels of inflammatory mediators such as IL-1␤, TNF-␣, PGE 2 , IFN-␥, and IL-8 can be detected in inflamed gingival tissues and gingival crevicular fluid (1, 2) .
Gingival fibroblasts, the major cell type in periodontal connective tissues, provide a tissue framework for tooth anchorage. Until recently, they were presumed to be immunologically inert. Currently, however, researchers recognize their active role in host defense. Upon stimulation with bacterial pathogens and their products, as well as with cytokines, gingival fibroblasts secrete various soluble mediators of inflammation such as IFN-␥, PGE 2 , IL-1, IL-6, and IL-8 (3-6) and up-regulate expression of HLA-DR and ICAM-1 (7). These fibroblast-derived mediators and surface Ags are thought to play an important role in periodontal inflammatory response. Recently, human gingival fibroblasts (HGFs) 3 have been demonstrated to express TLRs 2, 4, and 9 (8 -10) . TLRs are recognized as key pathogen recognition receptors that sense microbial invasion. TLR ligation triggers inflammatory innate immune response, which is critical for pathogen elimination (11) . It is likely that the release of inflammatory mediators from HGFs in response to microbial stimuli occurs via TLR triggering.
Recent findings also suggest that fibroblasts play an important role in negative feedback inhibition of inflammatory T cell response. IFN-␥-treated dermal fibroblasts express IDO (12, 13) . IDO is known as an enzyme that catabolizes tryptophan, an essential amino acid. Immune inhibitory effects by IDO is due to tryptophan depletion and/or cytotoxic effects by the tryptophan metabolites, such as kynurenine, 3-hydroxykynurenine, and 3-hydroxyanthranilic acid (14, 15) . Recent observation showed that a synthetic derivative of the tryptophan metabolite anthranilic acid reversed paralysis in mice with experimental autoimmune encephalomyelitis by suppression of myelin-reactive T cell responses (16) . It is becoming clear that IDO can act as a critical immune suppressive molecule responsible for the attenuation of T cell hyperactivity.
Gingiva, the outer layer of the oral cavity, is consistently exposed to ϳ500 bacterial species of both commensal and pathogenic bacteria (17) . How the oral tissues orchestrate their response to bacterial stimuli via TLR signaling, and thereby either maintain homeostasis or mediate expression of disease, is thus a very important research topic. We investigated the local innate immune response and immune regulation by focusing on TLR expression of HGFs and on their function after triggering by their specific ligands.
Materials and Methods

Reagents and Abs
Medium for HGF cultures was DMEM that was purchased from Invitrogen Life Technologies. The medium was supplemented with penicillin G (50 U/ml), streptomycin (50 g/ml), Fungizone (2.5 g/ml), and 10% heatinactivated FCS. Highly purified TLR ligands including LPS from Porphyromonas gingivalis (TLR2 ligand), poly(I:C) (TLR3 ligand), LPS from Escherichia coli K12 strain (TLR4 ligand), flagellin from Salmonella typhimurium (TLR5 ligand), loxoribine (guanosine analog, TLR7 ligand), and single-stranded poly(U) oligonucleotide complexed with LyoVec (TLR8 ligand) were obtained from InvivoGen. CpG ODN 2006 (TLR9 ligand) was obtained from Coley Pharmaceutical Group. IFN-␥ and TNF-␣ were purchased from R&D Systems. Anti-human TLR3 mAb (TLR3.7) was obtained from eBioscience. Both 1-methyl-DL-tryptophan and L-tryptophan were purchased from Sigma-Aldrich.
Human gingival fibroblasts
Gingival tissue samples were collected from subjects who had clinically healthy periodontium and no history of periodontitis. The gingival biopsies were obtained at the time of the crown-lengthening procedure for prosthetic reasons from the Periodontal Clinic, Faculty of Dentistry (Chulalongkorn University). Before operation, ethical approval was obtained from the ethics committee of the Faculty of Medicine, Chulalongkorn University, and informed consent was obtained from each subject. Fibroblasts from the gingival tissues were obtained following established procedure (18) . In brief, the excised tissue was immediately washed and then minced with scissors into fragments (1-3 mm 2 ) and placed in 60-mm tissue culture dishes. After a confluent monolayer of cells was reached, HGFs were trypsinized, washed twice, and then transferred to new tissue culture flasks. The HGF cultures at passages four to eight were used throughout the study.
Preparation of P. gingivalis sonicates P. gingivalis FDC-381 was cultured in trypticase soy broth (SigmaAldrich) at 37°C under an anaerobic chamber (Thermo Electron). The bacteria were harvested by centrifugation (Beckman Coulter) at 2000 ϫ g for 15 min and washed twice in PBS. The purity was assessed by Gram staining and colony morphology on trypticase soy agar. The microorganisms were subjected to sonication with high-density ultrasonication (High Intensity Ultrasonic Processor, microprocessor controlled 600-W model; Sonics and Material) at 4°C for 20 min elapsed time, with pulse on 2.5 s and pulse off 2 s. The sonicated extracts were examined microscopically for complete breakage of cells. Protein concentration of the sonicates was determined by using a Bio-Rad protein assay. The bacterial stock was aliquoted and stored at Ϫ20°C until use.
mRNA expression of TLRs in HGFs
Total RNA from HGFs was isolated by using a RNeasy Mini Kit from Qiagen. One microgram of DNase I-treated total RNA was reverse transcribed using ImProm-II Reverse Transcription System for RT-PCR (Promega). TLRs 1-10 and GAPDH were amplified using specific primers purchased from Sigma-Aldrich as described as follows and the PCR conditions were described as in previous studies (19, 20) : TLR1 (5Ј-CGTAAA ACTGGAAGCTTTGCAAGA-3Ј/5Ј-CCTTGGGCCATTCCAAATAAGT CC-3Ј); TLR2 (5Ј-GGCCAGCAAATTACCTGTGTG-3Ј/5Ј-CCAGGTAG GTCTTGGTGTTCA-3Ј); TLR3 (5Ј-ATTGGGTCTGGGAACATTTCTC TTC-3Ј/5Ј-GTGAGATTTAAACATTCCTCTTCGC-3Ј); TLR4 (5Ј-CTG CAATGGATCAAGGACCA-3Ј/5Ј-TCCCACTCCAGGTAAGTGTT-3Ј); TLR5 (5Ј-CCTCATGACCATCCTCACAGTCAC-3Ј/5Ј-GGCTTCAAGG CACCAGCCATCTC-3Ј); TLR6 (5Ј-ACTGACCTTCCTGGATGTGG-3Ј/ 5Ј-TGGCACACCATCCTGAGATA-3Ј); TLR7 (5Ј-ACAAGATGCCTT CCAGTTGC-3Ј/5Ј-ACATCTGTGGCCAGGTAAGG-3Ј); TLR8 (5Ј-CA GAATAGCAGGCGTAACACATCA-3Ј/5Ј-AATGTCACAGGTGCATTC AAAGGG-3Ј); TLR9 (5Ј-GCGAGATGAGGATGCCCTGCCCTACG-3Ј/ 5Ј-TTCGGCCGTGGGTCCCTGGCAGAAG-3Ј); TLR10 (5Ј-GGCCAG AAACTGTGGTCAAT-3Ј/5Ј-AACTTCCTGGCAGCTCTGAA-3Ј); and GAPDH (5Ј-TCATCTCTGCCCCCTCTGCTG-3Ј/5Ј-GCCTGCTCACCACC TTCTTG-3Ј).
Flow cytometric analysis of TLR3 expression
The specific localization of TLR3 of the HGFs was investigated by flow cytometry. For surface TLR3 staining, HGFs were incubated with PEconjugated anti-human TLR3 mAb (clone TLR3.7, 1 g) for 30 min at 4°C. For intracellular staining, cells were pretreated with fixation/permeabilization solution (BD Pharmingen) for 20 min at 4°C, washed once with PBS, and then incubated with the same mAb for 1 h at 4°C. Mouse isotype mAbs conjugated with PE was used as control. The stained cells were then analyzed on a FACSCalibur (BD Biosciences).
TLR ligation on HGFs after stimulation with TLR ligand(s) and/or cytokine
HGFs (1.5 ϫ 10 5 cells/ml) in 96-well plates or 24-well plates (Corning Glass) were treated with either 1) various single TLR ligands: P. gingivalis LPS (50 g/ml), poly(I:C) (100 g/ml), E. coli LPS (10 g/ml), Salmonella typhimurium flagellin (5 g/ml); loxoribine (100 M), ssPolyU (5 g/ml), and CpG ODN 2006 (10 g/ml); 2) TLR ligand combinations: P. gingivalis LPS (50 g/ml) plus poly(I:C) (100 g/ml), P. gingivalis LPS (50 g/ml) plus E. coli LPS (10 g/ml), P. gingivalis LPS (50 g/ml) plus S. typhimurium flagellin (5 g/ml), P. gingivalis LPS (50 g/ml) plus CpG ODN 2006 (10 g/ml), poly(I:C) (100 g/ml) plus E. coli LPS (10 g/ml), poly(I:C) (100 g/ml) plus S. typhimurium flagellin (5 g/ml), poly(I:C) (100 g/ml) plus CpG ODN 2006 (10 g/ml), E. coli LPS (10 g/ml) plus S. typhimurium flagellin (5 g/ml), E. coli LPS (10 g/ml) plus CpG ODN 2006 (10 g/ml), or S. typhimurium flagellin (5 g/ml) plus CpG ODN 2006 (10 g/ml); 3) cytokines: IFN-␥ (100 U/ml) and TNF-␣ (50 ng/ml); or 4) TLR ligand and cytokine combinations: P. gingivalis LPS (50 g/ml) plus IFN-␥ (5 U/ml), poly(I:C) (10 g/ml) plus IFN-␥ (5 U/ml), E. coli LPS (10 g/ml) plus IFN-␥ (5 U/ml), S. typhimurium flagellin (5 g/ml) plus IFN-␥ (5 U/ml), P. gingivalis LPS (50 g/ml) plus TNF-␣ (1 ng/ml), poly(I:C) (10 g/ml) plus TNF-␣ (1 ng/ml), E. coli LPS (10 g/ml) plus TNF-␣ (1 ng/ml), and S. typhimurium flagellin (5 g/ml) plus TNF-␣ (1 ng/ml).
After stimulation with TLR ligand(s) and/or cytokine for 12-24 h, the cells and culture supernatants were collected for measurement of IL-8 and IDO expression.
Determination of IL-8
The supernatants of HGFs after stimulation with TLR ligand(s) and/or cytokine were harvested and assessed for IL-8 production by ELISA (R&D Systems).
mRNA expression of IDO
The kinetics study of IDO mRNA expression (6, 12 , and 24 h) was conducted using IFN-␥-or TNF-␣-treated HGFs. Twelve-hour-treated cells showed optimal mRNA expression of IDO. The total RNA of HGFs after 12 h of stimulation with TLR ligand(s) and/or cytokine was reverse transcribed and treated with DNase I as previously mentioned. IDO was amplified using specific primer (5Ј-CTTCCTGGTCTCTCTATTGG-3Ј/5Ј-GAAGTTCCTGTGAGCTGGT-3Ј; Sigma-Aldrich) (21) . The expected size of the PCR product was 430 bp. For semiquantitative RT-PCR analysis, band intensities on scanned gels were analyzed (GeneTools; Synoptics) using specific bands of the housekeeping gene GAPDH as a reference.
IDO activity: kynurenine assay
IDO-dependent catabolism of tryptophan produces kynurenine. Hence, the biological activity of IDO was evaluated by measuring the level of kynurenine in HGF culture supernatants (22) . One hundred microliters of culture supernatants of HGFs after stimulation with TLR ligand(s) and/or cytokine was mixed with 50 l of 30% trichloroacetic acid, vortexed, and centrifuged at 8000 ϫ g for 5 min. Then, 75 l of the supernatant was added to an equal volume of Ehrlich reagent (100 mg of p-dimethylbenzaldehyde in 5 ml of glacial acetic acid) in a 96-well microtiter plate, and the absorbance was read at an OD of 492 nm. A standard curve of defined kynurenine concentration (0 -100 M) permitted analysis of unknowns.
Suppression of T cell response in MLR
To assess whether IDO-expressed HGFs inhibit allogeneic T cell responses, MLRs were performed on a layer of HGFs that had been treated for 2 days with either P. gingivalis LPS (50 g/ml), IFN-␥ (5 U/ml), or the combination of P. gingivalis (50 g/ml) and IFN-␥ (5 U/ml). PBMC were isolated from the blood of healthy human donors. MLCs were performed by mixing PBMC (each at 4 ϫ 10 7 cells/ml in PBS) from two healthy donors. A total of 4 ϫ 10 5 mixed PBMC in 10 l of PBS was cocultured with a confluent layer of stimulated HGFs (200 l/well) in 96-well plates. 3 [H]Thymidine (0.5 Ci/200 l/well) was added on day 5 and cell cultures were incubated for another 18 h. Cells were harvested onto glass filter paper and radioactivity was measured (beta plate; PerkinElmer Wallac). To confirm the inhibitory effect of IDO, 1-methyl-DL-tryptophan (1000 g/ml) or L-tryptophan (1000 M) was added during the coculture of the stimulated HGFs with mixed PBMC.
Statistical analysis
Statistical comparisons among treatment conditions with respect to production of IL-8 and IDO and to inhibition of the T cell response were analyzed using SigmaStat (Jandel). The parametric Student's t test was used for normally distributed data, and the nonparametric Mann-Whitney U rank-sum test was used for nonnormally distributed data. A value of p Ͻ 0.05 was considered statistically significant.
Results
mRNA expression of TLRs on HGFs
TLRs have been found on many cell types and are known to play a central role in pathogen recognition in the innate immune system. To evaluate the expression of TLRs in HGFs, total RNA from HGFs was analyzed by RT-PCR using a panel of specific primers of TLRs 1-10. We found the mRNA expression of TLRs 1, 2, 3, 4, 5, 6, and 9 on HGFs but not TLRs 7, 8, and 10 (Fig. 1A) . The results were reproducible in all four HGF lines. Human PBMC were used as a positive control and shown to express all mRNA of TLRs 1-10 (Fig. 1B) .
TLR3 is generally recognized as an intracellular receptor, but a recent study showed a surface TLR3 on human skin and lung fibroblasts (23) . Thus, we analyzed the specific location of TLR3 expression in HGFs. Using the same mAb specific to TLR3 (clone TLR 3.7), we demonstrated the detection of intracellular TLR3 on HGFs but not on the cell surface (Fig. 2) .
We next evaluated whether TLR expression could be modulated by oral bacterial products. Coculture of HGFs with sonicated extracts of P. gingivalis for 24 h did not lead to a significant upregulation of any TLR mRNA expression (data not shown).
TLR ligands stimulate expression of IL-8 and IDO
To characterize the functional relevance of TLRs in HGFs, expression of IL-8 and IDO was determined after stimulation with highly purified TLR ligand(s). IL-8 production coincided with mRNA expression of TLRs (i.e., TLRs 2, 3, 4, and 5; Fig. 3A) . On the contrary, no IL-8 production was observed in HGFs stimulated with CpG ODN 2006, even though the cells expressed TLR9 mRNA (Fig. 3A) .
Skin fibroblasts are known to express IDO when treated with IFN-␥ (12, 13) . In this study, the IDO expression of HGFs after TLR ligation was also evaluated. Similar to IL-8 production, P. gingivalis LPS, poly(I:C), E. coli LPS, and S. typhimurium flagellin, respective ligands for TLRs 2, 3, 4, and 5, induced IDO mRNA expression. IFN-␥-and TNF-␣-treated HGFs were used as positive controls (Fig. 3B) .
TLR ligand combinations (P. gingivalis LPS plus poly(I:C), P. gingivalis LPS plus E. coli LPS, P. gingivalis LPS plus S. typhimurium flagellin, P. gingivalis LPS plus CpG 
Combination of TLR ligand and cytokine stimulates expression of IL-8 and IDO
Cytokines IFN-␥, and TNF-␣ have been consistently detected in periodontitis lesions (6, 7). We next investigated the effects on HGF production of IL-8 and IDO by either cytokine or by the combination of cytokine with different TLR ligands, specifically P. gingivalis LPS, poly(I:C), E. coli LPS, or S. typhimurium flagellin. 
P. gingivalis LPS and/or IFN-␥-treated HGFs induce suppression of T response via IDO
According to the enhancement of IDO mRNA expression on HGFs after stimulation with the combination of P. gingivalis LPS and IFN-␥, we next assessed the biological activity of IDO by measuring the kynurenine concentration in those cultured supernatants. Fig. 6A demonstrates that the kynurenine could be detected within 24-h culture supernatants of stimulated HGFs. The levels of kynurenine continued to increase up to 72 h in cultures. We further evaluated whether HGFs, which were stimulated with P. gingivalis LPS, IFN-␥, or the two in combination could inhibit T cell response in MLRs. Cocultures of mixed PBMC with 2-day P. gingivalis-or IFN-␥-stimulated HGF showed 10 -32% inhibition of the T cell proliferative response ‫,ء(‬ p Ͻ 0.05) as compared with unstimulated HGFs. However, the combination of P. gingivalis and IFN-␥-stimulated cells markedly inhibited T cell proliferation by 62% ‫,ءء(‬ p Ͻ 0.001; Fig. 6B ). The response of T cells was restored when 1-methyl-DL-tryptophan or L-tryptophan was added to the cultures (Fig. 6B) .
Discussion
It is known that host immune response employs TLR and non-TLR pathways to recognize pathogens and commensal bacteria (24, 25) . This recognition leads to expression of mediators that limit microbial invasion. When gingival epithelium is ruptured, HGFs can be exposed to many bacterial pathogen-associated molecular patterns (PAMPs). Clinical observations demonstrated the presence of periodontopathic bacteria in epithelial and connective tissue layers of periodontitis lesions (26 -33) . The pathogens such as P. gingivalis, A. actinomycetemcomitans, and Fusobacterium nucleatum were also shown to invade human gingival epithelial cells and fibroblasts in vitro as well as in vivo (34 -37) . The ability of HGFs to recognize and respond to such patterns renders them crucial in dealing with microbial invasion. In this study, we evaluated the expression of TLRs and their role in signaling by HGFs. Our results demonstrate that HGFs derived from healthy gingival tissues expressed mRNA of TLRs 1, 2, 3, 4, 5, 6, and 9, but not of TLRs 7, 8, and 10 . This is similar to observations in nasal fibroblasts (38) . A recent study showed that fibroblasts from human foreskin and lung expressed cell surface TLR3 (23) . However, our study, using the same clone of mAb, demonstrated the presence of intracellular TLR3, but not cell surface TLR3, on HGFs. Thus, fibroblast TLR expression may differ across anatomic sites. Further study is needed to identify and compare the physiologic significance of intracellular and cell surface TLR3.
In line with the TLR mRNA expression, HGFs expressed IL-8 and IDO in response to P. gingivalis LPS, poly(I:C), E. coli LPS, and S. typhimurium flagellin, respective ligands for TLRs 2, 3, 4, and 5. It has been shown that highly purified P. gingivalis LPS possess lipid A heterogeneity, which may contribute to their ability to interact with either TLR2 or TLR4 (39) . P. gingivalis LPS at a concentration of 50 g/ml used in our study predominantly stimulated HGFs via TLR2 and to a lesser extend via TLR4 (InvivoGen product information). Poly(I:C) appeared to induce higher IL-8 and IDO expression than did other TLR ligands. Surprisingly, CpG ODN 2006, a potent ligand for TLR9, did not induce IL-8 or IDO expression. Similarly, purified DNA derived from either E. coli, P. gingivalis, or A. actinomycetemcomitans, which is also recognized as a TLR9 ligand, did not induce either of these mediators (data not shown). Our findings may indicate a nonfunctional TLR9 in HGFs. (Gingival epithelial cells also express TLR9 mRNA, but do not respond to CpG ODN 2006; R. Mahanonda and S. Pichyangkul, unpublished observations.) In contrast, some recent studies showed that DNA preparation from periodontopathic bacteria activated HGFs via TLR9 to produce IL-6 or IL-8 (10, 40) . This inconsistency requires further investigation.
The finding that HGFs expressed TLRs 2, 4, and 5 supports their role in the innate immune response against bacteria. Oral plaque bacteria are known to have PAMPs that are recognized by TLRs 2, 4, and 5. For example, P. gingivalis LPS and P. gingivalis fimbriae are recognized by TLR2 (41) (42) (43) ; LPS from A. actinomycetemcomitans and Bacteroides fragilis are recognized by TLR4 (44 -46) . Flagellin of Treponema denticola is most likely recognized by TLR5. The expression of TLR3 in HGFs is interesting because TLR3 recognizes dsRNA, a by-product of viral replication and transcription (47) . A possible role of herpesviruses in etiology and severity of periodontal diseases has been reported (48 -50) Previous studies demonstrated that different cytokines have different effects on HGFs in IL-8 production (3, 51). TNF-␣, but not IFN-␥, induced IL-8 production from HGFs; these observations agree with those of previous studies (3, 51, 52) . Combinations of cytokines and bacterial PAMPs are known to modulate cytokine production from different cell types (53, 54) . A high level of IL-8 as well as the increased presence of IL-8-secreting fibroblasts has been detected in periodontitis lesions (6, 55) . Our data demonstrate that stimulation of HGFs with TNF-␣, combined with TLR ligands 2, 4, or 5, synergistically enhanced IL-8 production. The IL-8 response in periodontal tissue could have both beneficial and deleterious effects. IL-8 is important in neutrophil activation and recruitment. On one hand, undue down-regulation of this function could compromise antimicrobial defense. On the other hand, unduly vigorous or sustained IL-8 response could cause chronic inflammatory tissue destruction.
It is reported that skin fibroblasts can dampen local immune cell responses via IDO. In this study, we demonstrated that HGFs were also able to induce IDO expression in response to P. gingivalis LPS, poly(I:C), E. coli LPS, and S. typhimurium flagellin. IDO expression was synergistically enhanced when HGFs were treated with the combination of some PAMPs (TLR ligands 2, 4, or 5) and IFN-␥. It is interesting that TNF-␣, which enhanced TLR ligandinduced IL-8 production, has a negligible effect on TLR ligandinduced IDO expression of HGFs. Marked suppression of T cell proliferation in MLRs was mediated by IFN-␥ and P. gingivalis LPS-treated HGFs. The suppression was reversible with the addition of either 1-methyl-DL-tryptophan or L-tryptophan, thus confirming that stimulated HGFs suppressed T cell response via induced IDO.
In conclusion, our study demonstrates that HGFs express mRNA of TLRs 1, 2, 3, 4, 5, 6, and 9. Triggering with P. gingivalis LPS, poly(I:C), E. coli LPS, and S. typhimurium flagellin, ligands specific for TLRs 2, 3, 4, and 5, respectively, led to the expression of IL-8 and IDO. In contrast, the potent TLR9 ligand CpG ODN 2006 did not induce IL-8 and IDO expression. Moreover, it specifically inhibited poly(I:C)-induced HGF activation. The ability to induce IL-8 and IDO expression in ligand-stimulated HGFs was enhanced when combined with cytokine TNF-␣ and IFN-␥, respectively. Finally, that HGFs can enhance IDO expression and down-regulate T cell response when stimulated with some PAMPcytokine combinations suggests that these strategically placed cells have an important role in modulating the unwelcome hyperreactive inflammatory reaction that periodontitis often entails.
